Mutual Fund Ownership
Ownership as on: Tue, 5 Mar, 2024

UTI S&P BSE Low Volatility Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)15.16
% of AUM5.34%

Motilal Oswal S&P BSE Low Volatility Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)2.03
% of AUM5.31%

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)10.35
% of AUM4.38%

Aditya Birla Sun Life MNC Fund Growth

NA
Equity
Amount Invested (Cr.)131.77
% of AUM3.67%

Quant Large and Mid Cap Fund Growth

5/5
Equity
Amount Invested (Cr.)50.85
% of AUM3.01%

FAQs about Glaxosmithkline Pharmaceuticals share price

Glaxosmithkline Pharmaceuticals is trading at 2130.00 as on Tue Mar 05 2024 09:59:01. This is -1.05% lower as compared to its previous closing price of 2152.55.

The market capitalization of Glaxosmithkline Pharmaceuticals is 36084.33 Cr as on Tue Mar 05 2024 09:59:01.

The average broker rating on Glaxosmithkline Pharmaceuticals is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glaxosmithkline Pharmaceuticals is 2649.95 whereas the 52 wk low is 1228.00

Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 60.78
  • Sector P/E: 21.77
  • Dividend Yield: 1.49%
  • D/E ratio: -

Glaxosmithkline Pharmaceuticals reported a net profit of 610.69 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,021.95+34.75(3.52%)
1,168.70+34.70(3.06%)
1,550.05-69.35 (-4.28%)
6,325.25-275.20 (-4.17%)